KOJIMA NAOKI,ROMAN J. RICHARD,MIYATA NORIYUKI,TAKAHASHI TEISUKE,TOMOIKE HIDEKI,TAKEDA TAKUYA
申请号：
IN1975DEN2015
公开号：
IN1975DEN2015A
申请日:
2015.03.11
申请国别(地区):
IN
年份:
2015
代理人:
摘要：
Provided is a medicinal agent or a treatment method in which a combination of an SGLT2 inhibitor and an anti hypertension drug is used and which is useful for the treatment of such diseases that at least hypertension or diabetes is included as a risk factor for a cardiovascular event. According to the present invention an excellent hypotensive effect which cannot be achieved when an anti hypertension drug is used alone can be achieved. Therefore the conventional problem of using at least two types of anti hypertension drugs for achieving a desired hypotensive effect can be solved. Furthermore the present invention exerts a significant therapeutic effect on diabetes a diabetes related disease or a diabetes complication particularly diabetic nephropathy. Furthermore the present invention is also useful for the treatment of a disease in which the renal function is deteriorated.
